The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 20.27

Cancer of the Oral Cavity and Pharynx (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2016
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to <5 5 to <10 10 to <15 15 to <20 20 to <24 0 to <24b >=24d
All Races Both Sexes 137,601 83,078 52,272 33,186 16,846 322,983 47,326 370,309
Males 97,382 56,660 34,723 21,268 10,139 220,172 29,888 250,059
Females 40,219 26,418 17,549 11,918 6,707 102,811 17,438 120,250
White Both Sexes 119,389 71,998 45,504 28,485 14,475 279,851 40,358 325,100
Males 85,471 49,690 30,750 18,599 8,853 193,362 25,529 222,024
Females 33,919 22,309 14,754 9,885 5,622 86,489 14,829 103,077
Black Both Sexes 10,229 5,844 3,613 2,443 1,333 23,462 2,368 25,830
Males 6,966 3,712 2,101 1,354 678 14,811 1,246 16,057
Females 3,262 2,132 1,512 1,090 655 8,651 1,121 9,773
Asian/
Pacific
Islander		 Both Sexes 5,206 3,370 2,197 1,497 670 12,941 + +
Males 3,161 2,040 1,290 850 380 7,721 + +
Females 2,045 1,330 907 647 290 5,220 + +
Hispanic Both Sexes 7,864 4,600 2,787 1,690 868 17,809 + +
Males 5,180 2,704 1,697 983 418 10,982 + +
Females 2,684 1,896 1,090 707 450 6,828 + +

Estimated prevalence percent a on January 1, 2016, of the SEER population diagnosed in the previous 24 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.1002 0.0004 0.0023 0.0066 0.0168 0.0488 0.1514 0.2996 0.3762 0.3571 0.0835
Males 0.1388 0.0004 0.0023 0.0062 0.0162 0.0604 0.2212 0.4620 0.5721 0.5369 0.1218
Females 0.0629 0.0004 0.0024 0.0071 0.0174 0.0374 0.0848 0.1524 0.2130 0.2464 0.0509
White Both Sexes 0.1110 0.0004 0.0021 0.0065 0.0162 0.0480 0.1574 0.3148 0.3973 0.3757 0.0868
Males 0.1548 0.0004 0.0020 0.0059 0.0153 0.0603 0.2321 0.4855 0.6023 0.5628 0.1269
Females 0.0680 0.0004 0.0023 0.0072 0.0172 0.0356 0.0846 0.1566 0.2228 0.2585 0.0518
Black Both Sexes 0.0520 0.0004 0.0029 0.0068 0.0144 0.0395 0.1077 0.2014 0.2167 0.1750 0.0546
Males 0.0685 0.0005 0.0031 0.0073 0.0142 0.0444 0.1503 0.3108 0.3419 0.2814 0.0791
Females 0.0369 0.0003 0.0027 0.0063 0.0146 0.0352 0.0705 0.1141 0.1295 0.1224 0.0366
Asian/
Pacific
Islander		 Both Sexes 0.0636 - 0.0022 0.0061 0.0237 0.0607 0.1289 0.1964 0.2441 0.2337 0.0650
Males 0.0792 - 0.0027 0.0058 0.0268 0.0733 0.1718 0.2771 0.3360 0.3056 0.0859
Females 0.0492 - 0.0017 0.0064 0.0208 0.0496 0.0918 0.1312 0.1703 0.1873 0.0479
Hispanic Both Sexes 0.0312 0.0005 0.0019 0.0048 0.0093 0.0284 0.0713 0.1499 0.2128 0.2184 0.0456
Males 0.0381 0.0006 0.0019 0.0047 0.0086 0.0323 0.0941 0.2145 0.2996 0.3112 0.0616
Females 0.0242 0.0003 0.0019 0.0050 0.0100 0.0243 0.0489 0.0927 0.1463 0.1610 0.0326

Footnotes:

a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2016 US population estimates based on the average of 2015 and 2016 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years.

b Maximum limited-duration prevalence is 24 years for 1992-2016 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing 0 to <24 and >=24.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.